Latest News about PTCT
Recent news which mentions PTCT
3 Top Stocks That Could Still Rocket Higher in 2024
October 04, 2024
From Motley Fool
Tickers
PTCT
From InvestorPlace
From Benzinga
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
June 21, 2024
From Benzinga
PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder
June 20, 2024
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
Overseas Shipholding, Micron, Squarespace, Incyte And Other Big Stocks Moving Higher On Monday
May 20, 2024
From Benzinga
From Benzinga
Tickers
PTCT
From InvestorPlace
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
March 01, 2024
From Benzinga
Earnings Scheduled For February 29, 2024
February 29, 2024
From Benzinga
From Motley Fool
PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe
January 26, 2024
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 26, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 27, 2023
From Benzinga
Why Is Gene Therapy Player PTC Therapeutics Stock Plunging Today?
October 27, 2023
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 27, 2023
From Benzinga
RBLX Stock Alert: Analysts Are Pounding the Table on Roblox
October 27, 2023
From InvestorPlace
Why Is PTC Therapeutics (PTCT) Stock Down 23% Today?
October 27, 2023
From InvestorPlace
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.